Bio-Rad (BIO) EV/EBITDA Multiple

Brandmark of Bio-Rad (BIO)

Bio-Rad Laboratories (BIO) relies on government science funding and clinical demand for diagnostics. The company handles system assembly in-house while partially outsourcing electronics. Low geopolitical risks ensure the stability of global supplies. The evolution of the EV/EBITDA ratio over time demonstrates the company's market value relative to earnings, with the metric holding at 22.61.

BIO Bio-Rad Laboratories, Inc.: Total Company Value to Operating Income Before Depreciation Ratio in the range 11/23/2025 - 11/10/2026

Analytical breakdowns for Bio-Rad Laboratories

- market price and analyst price targets:
Price Chart Bio-Rad Laboratories Inc|BIO - Analyst Median Target
- market capitalization details:
Market Capitalization Bio-Rad Laboratories|BIO - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share Bio-Rad|BIO - Book Valuation of Business|Market Capitalization to Book Value Ratio bio-rad.com|BIO - Aggregate Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Bio-Rad Laboratories|BIO - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Bio-Rad|BIO - Company Cumulative Debt|Debt to Book Value Bio-Rad Laboratories|BIO - Long-Term Indebtedness|Company Short-Term Debt Bio-Rad|Quick Ratio bio-rad.com
- business earnings and investment ratios data:
BIO - Net Profit|Projected Future Earnings Bio-Rad Laboratories|BIO - Price to Earnings Multiple|Projected Price to Earnings Bio-Rad Laboratories|BIO - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bio-Rad Laboratories|BIO - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Bio-Rad|BIO - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth bio-rad.com|BIO - Earnings per share growth in current year|Net earnings per share growth forecast for next year Bio-Rad Laboratories
Initial company analysis:Bio-Rad Laboratories Inc (BIO)
Product sample of Bio-Rad

This indicator compares the aggregate value of assets and liabilities with operating profit before taxes and depreciation, allowing for an assessment of the business's real value regardless of the capital structure. By analyzing the enterprise value to EBITDA ratio of Bio-Rad Laboratories (BIO), an investor can see how the Schwartz family's conservative management style influences the market valuation of Bio-Rad Laboratories (BIO) amid cautious resource allocation.

Main competitors

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Agilent Tech A|Total Company Value to Operating Income Before Depreciation Ratio Quest Corp (DGX)|Illumina, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|Revvity (RVTY) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|NNNN - Total Company Value to Operating Income Before Depreciation Ratio|SHC (Sterigenics) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization QDEL|EV/EBITDA Multiple OPK|Total Company Value to Operating Income Before Depreciation Ratio CareDx, Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Maravai LifeSciences Holdings, Inc. MRVI|Fulgent Genetics Inc (FLGT) - Company Value to EBITDA|LAB: Enterprise Value to EBITDA Ratio|Enterprise Value to EBITDA Multiple Cytek Corp (CTKB)|OraSure Technologies (OSUR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Exagen - Business Value to Operating Income Before Depreciation|MDXH (MDxHealth) - EV/EBITDA Multiple|EV/EBITDA Multiple Lucid Diagnostics, Inc.|EV/EBITDA Multiple PRE|imdxinc.com - Enterprise Value to Operating Income Before Depreciation|Trinity Biotech - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation PRPH|AIMD - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CODX: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HSCS: EV/EBITDA Multiple|Biomerica Inc (BMRA) - EV/EBITDA Multiple|CDIO (Cardio Diagnostics Holdings Inc.) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ONCO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Virax Biolabs (VRAX)|BJDX - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vermillion AWH|Business Value to Operating Income Before Depreciation AXDX|CENTOGENE, N.V. - EV/EBITDA Multiple|ENZ - EV/EBITDA Multiple|FRES (fresh2.co) - Enterprise Value to EBITDA Ratio|GENE: Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization 23andMe Inc.|Company Value to EBITDA Psychemedics Inc PMD